Tips for Choosing a Reimbursement Hub Partner

Posted on

A professional Reimbursement Specialist can prove a brilliant outsource asset to help assist patients with access to medicines. These support specialists are experts at guiding patients, caregivers, and healthcare providers through a complex maze of services to ease frustrations and conflicts and access medicines. Too, with the exploding growth of specialty pharmacies, the role of […]


Checking In on Medical Cost Trends for the Coming Year

Posted on

Ready for a peek at trends for 2018? PwC’s Health Research Institute’s annual report, released this month, analyzes medical cost trends by projecting the percentage of increase in cost to treat patients for a 12-month period. The 33-page report goes to the “heart of the matter” and projects 2018 medical costs will grow at a […]


Remote Monitoring? Another Way WRB Provides Value

Posted on

Medical diagnostics and treatment have become so complex and cumbersome today that almost any idea of alleviating time or tension for patients and physicians can be a welcome intervention. Take remote monitoring for example. Remote monitoring/home telehealth allows the delivery of healthcare from an episodic model to a remote one of continuous monitoring, particularly helpful […]


How to Navigate the Maze of Prescription Affordability

Posted on

The cost of prescriptions and the ability of Americans to afford them continues as a complex and significant issue in health care. A Kaiser Health survey confirmed that more than 25 percent of people taking medications struggle to afford them, and experts tell us nearly 20 percent of patients with chronic illnesses admit to underusing, […]


Fill the Pharma Gap with Inside Sales and Boost Revenue

Posted on

 Pharmaceutical companies’ field sales representatives were the stuff made of legends. While gone are the overabundance of field reps touting their branded best-sellers to doctors, so also went the personal touch that they provided. Was that the baby with the bathwater? Though, access to physicians may still be minimized an argument can be made that […]


How to Optimize your Brand

Posted on

Advertising experts have always touted good word-of-mouth advertising as the supreme way to sell a product.  Today, the process, now named word of mouth marketing (WOMM), still reigns as a power in marketing. A hefty ROI arises from a savvy WOMM strategy that includes multiple channels, especially the dialogue between providers and patients because customers […]


Competent Partners Provide Case Management Reimbursement Support for Rare Diseases

Posted on

Not every patient falls within the “usual patient diseases” groupings for which exist choices of treatments. For the one in 10 persons who has a rare disease (there are about 7,000 identified at this time), less than 10% of those diseases have an FDA-approved treatment. Rare diseases present an opportunity for manufacturers to drive patient […]


Patient Assistance Programs Help Patients Afford Medications

Posted on

Prescription affordability continues to push to the forefront of significant issues in healthcare. However, both physicians and patients are caught in the tug of which prescriptions to use, with decisions made in favor of price. The result is due to cost and why patients with chronic illnesses often fall out of adherence with medications. Nearly […]


Case Study: Comparison of Insourcing vs. Outsourcing to a Contact Center

Posted on

The reasons that influence a company’s decision to insource or outsource selected operations or functions of its business run as unique as each business. While those reasons do not comprise the topic of this case study, note that cost is a significant factor in a company’s decision whether to insource or outsource. It may surprise […]


Will the 21st Century Cures Act Promote New Cures?

Posted on

The 21st Century Cures Act (Act) passed through Congress with a vote of 94-to-5. One of the goals of the Act is to get medications and devices to market more quickly. However, could it be dangerous to ease experimental treatments through FDA guidelines? Or is this the panacea for giving more patients a fighting chance? […]